K2LTS Brain Rehabilitation

Manufacturer
K2LT LAB, LLC
Effective date
2024-09-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 20:55:14

Label at a glance#

ProductK2LTS Brain Rehabilitation
Active ingredientGLUTATHIONE
Label structure13 sections

Dosage and administration

Twist the cap and administrate directly; Twice a day. Do not exceed the recommended dosage.

Storage and handling

Storage Method:The product should be stored in a cool, dry, and dark environment with a temperature range of 16°C to 27°C(60-80℉), and humidity not exceeding 50%.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ASK DOCTOR SECTION

Glutathione 25mg(12.5%)

Purpose

OTC - PURPOSE SECTION

For early Alzheimer's Disease

Use

INDICATIONS & USAGE SECTION

This product is mainly indicated for the treatment of memory impairment and mild to moderate brain dysfunction due to a variety of causes.

Maintaining the levels of BDNF to promote the generation of neurons, and assisting in helping and maintaining positive mood;

Warnings

WARNINGS SECTION

The administration of Brain Rehabilitation may lead to certain adverse reactions, including gastrointestinal symptoms (such as nausea, abdominal discomfort, anorexia, bloating, and abdominal pain), These symptoms are generally mild and tend to resolve upon discontinuation of the drug.

Do not use

OTC - DO NOT USE SECTION

1. This product is contraindicated for who are allergic to it.
2. This product must not be combined with antibiotic drugs.

When Using

OTC - WHEN USING SECTION

When utilizing Brain Rehabilitation, please thoroughly read the instructions for use and strictly follow the doctor’s advices. Self-adjustment of the dosage or alteration of the administration method is strictly prohibited.

The concurrent use of drugs or an increased exposure to this product may lead to clinically significant adverse reactions.

Stop Use

OTC - STOP USE SECTION

Stop use and ask a doctor if irritation or rash occurs.

Ask Doctor

OTC - ASK DOCTOR SECTION

Stop use and ask a doctor if irritation or rash occurs.

Keep Out Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Please keep this product away from children. If the child accidentally ingests this product, please seek medical help immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Twist the cap and administrate directly; Twice a day. Do not exceed the recommended dosage.

Other information

STORAGE AND HANDLING SECTION

Storage Method:The product should be stored in a cool, dry, and dark environment with a temperature range of 16°C to 27°C(60-80℉), and humidity not exceeding 50%.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Jellyfish protein 35mg, Phosphatidylserine 20mg, L-threonine magnesium 20mg, CBD 20mg, Taurine 15mg, Ergothioneine 15mg, Urolithin A 15mg, Spermidine 10mg, Vitamin E 10mg.

Other ingredients

Xanthan gum 10mg, Sodium benzoate 3mg, Borneol 2mg.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84429-004K2LTS BRAIN REHABILITATION (BRAIN REHABILITATION) LIQUID [K2LT LAB, LLC]1Unmatched20240912_21d04d5d-48cf-2155-e063-6294a90a59d2.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84429-00484429-004-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
496a0012-6672-1006-e063-6294a90af48821d04d5d-48cf-2155-e063-6294a90a59d22026-01-27WarningsExact identifier
spl set id: 21d04d5d-48cf-2155-e063-6294a90a59d2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.